Multiply Labs today announced an agreement with AstraZeneca to evaluate the potential for applying GMP-ready robotic systems to commercial-scale cell therapy manufacturing. Multiply Labs is a current ...
Vention has raised Series D funding to continue commercializing its robot control platform and expand into Europe.
Collaborative robots, or cobots, are required to maintain compliant interaction while delivering rapid response performance ...